LFB USA is a company within the LFB Group, a leading European biopharmaceutical company specialized in innovative biotherapies, marketing its medicinal products around the world.

At LFB USA, we are powering the development and commercialization of highly innovative recombinant therapies to address an ever-growing set of unmet medical needs. To do this effectively, we …

LFB USA is a globalized company which develops and provides pharmaceutical bioproducts through its innovative technologies for patients with serious diseases. LFB USA is committed to overcoming …

The proprietary rPRO Technology ™ that drives LFB S.A.'s product development enables production of innovative recombinant therapies that are more cost-effective and scalable compared to traditionally …

Contact Corporate headquarters for LFB USA: LFB USA, Inc. 175 Crossing Blvd. Framingham, MA 01702

LFB USA has a key role in developing LFB's pipeline in the US, focusing on research, clinical development and regulatory strategies and filings. For the Factor FVIIa (LR769) program, LFB USA …

Framingham biopharmaceutical firm LFB USA has pinned plans to build a new 65,000-square-foot manufacturing and laboratory facility in Marlborough in part on the expectation that its drug, ATryn, …

LFB USA is led by a team of business experts and scientists with a successful track record of developing and commercializing important and highly innovative healthcare technologies and life …

For a link to the FDA article: https://www.fda.gov/news-events/press-announcements/fda-approves-additional-treatment-adults-and-adolescents-hemophilia-or-b-and-inhibitors Click here for the official …

Within the LFB Group, which is a leader in the field of therapeutic proteins in France, LFB USA enables the production of life-saving medicines within the Group’s key areas of expertise and focus – …